Internship

Intern – Regulatory Affairs

Oncology

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Biotechnology
Healthcare

Compensation Overview

$19 - $55Hourly

No H1B Sponsorship

San Mateo, CA, USA

Must be able to relocate if necessary and work at the designated site for the duration of the internship.

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Interns will assist the Global Regulatory Affairs Oncology Liaison team with projects to support department goals and objectives.
  • Interns will assist with development and submission of regulatory documents such as clinical study reports, study protocols and protocol amendments, and assist with activities in preparation for annual reporting requirements (e.g., Investigator Brochure, Orphan Annual report, etc.).
  • In addition, the intern work across the global regulatory network on various research projects and present their findings at team meeting and a final poster board presentation at the conclusion of their internship

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D, maintaining a diverse pipeline of potential treatments, and forming strategic partnerships to enhance its offerings. The company's goal is to improve health equity and access to care globally, working with communities to remove barriers to healthcare and ensure that its medicines reach those in need.

Company Stage

IPO

Total Funding

$15.9B

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with Terray Therapeutics boosts drug discovery and pipeline diversification.
  • Dietmar Berger's appointment strengthens leadership in clinical development and regulatory affairs.
  • Investment in Xilio Therapeutics expands Gilead's oncology portfolio with innovative therapies.

What critics are saying

  • Increased competition in immuno-oncology could impact Gilead's market share.
  • Challenges in Terray partnership may affect returns if therapies underperform.
  • New CMO's strategic shifts might disrupt Gilead's current R&D focus.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of new treatments.
  • Gilead's strategic partnerships enhance its product offerings and market reach globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options